Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2023-08-11

SEC-registered investment adviser since 2014 · limited liability company

Assets managed$4.5bn
Staff11 · 11 in investment roles
Main clients (by assets)Private funds 100%
Private funds7 (1 hedge) · $4.5bn gross assets
Form ADV · 2026-04-28SEC adviser record

Legal entityVENROCK ADVISER, LLC (US)

$625.4m reported value +22.1% vs Q1 2023

30positions

69.5%in top 10

10 new 5 added 4 reduced 5 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	VIRIDIAN THERAPEUTICS INC COM VRDN	VRDN	3,082,622	$73.3m11.73%	11.73%	Added +382.8k	+382,757 14.2%
2	COGENT BIOSCIENCES INC COM COGT	COGT	4,684,132	$55.5m8.87%	8.87%	Reduced -200.8k	-200,845 -4.1%
3	4D MOLECULAR THERAPEUTICS IN COM FDMT	FDMT	3,000,000	$54.2m8.67%	8.67%	New
4	ENLIVEN THERAPEUTICS INC COM ELVN	ELVN	2,230,127	$45.5m7.28%	7.28%	Added +16.0k	+15,985 0.7%
5	MERUS N V COM MRUS	MRUS	1,726,214	$45.5m7.27%	7.27%	Added +500.0k	+500,000 40.8%
6	GH RESEARCH PLC ORDINARY SHARES GHRS	GHRS	3,517,125	$41.7m6.67%	6.67%	Unchanged
7	AMBRX BIOPHARMA INC SPONSORED ADS SPONSORED ADS		2,484,960	$40.9m6.54%	6.54%	Reduced -813.6k	-813,617 -24.7%
8	KALVISTA PHARMACEUTICALS INC COM KALV	KALV	2,916,667	$26.3m4.20%	4.20%	Unchanged
9	TERNS PHARMACEUTICALS INC COM COM		2,972,869	$26.0m4.16%	4.16%	Reduced -646.7k	-646,653 -17.9%
10	CABALETTA BIO INC COM CABA	CABA	1,973,251	$25.5m4.07%	4.07%	Unchanged
11	DYNE THERAPEUTICS INC COM DYN	DYN	2,173,913	$24.5m3.91%	3.91%	New
12	CELCUITY INC COM CELC	CELC	2,105,386	$23.1m3.70%	3.70%	Unchanged
13	SAVARA INC COM SVRA	SVRA	6,351,531	$20.3m3.25%	3.25%	Unchanged
14	PHARVARIS N V COM PHVS	PHVS	1,326,200	$20.1m3.21%	3.21%	New
15	RHYTHM PHARMACEUTICALS INC COM RYTM	RYTM	1,090,000	$18.0m2.87%	2.87%	New
16	ORIC PHARMACEUTICALS INC COM ORIC	ORIC	2,142,856	$16.6m2.66%	2.66%	New
17	ACLARIS THERAPEUTICS INC COM ACRS	ACRS	1,040,754	$10.8m1.73%	1.73%	Unchanged
18	TREVI THERAPEUTICS INC COM TRVI	TRVI	3,422,397	$8.2m1.31%	1.31%	Added +372.4k	+372,375 12.2%
19	APPLIED THERAPEUTICS INC COM APLT	APLT	5,658,034	$7.2m1.16%	1.16%	New
20	THESEUS PHARMACEUTICALS INC COM COM		770,000	$7.2m1.15%	1.15%	Unchanged
21	MILESTONE PHARMACEUTICALS IN COM MIST	MIST	2,208,812	$6.3m1.01%	1.01%	Unchanged
22	ADVERUM BIOTECHNOLOGIES INC COM COM		3,886,246	$6.2m0.99%	0.99%	New
23	PRAXIS PRECISION MEDICINES I COM COM		5,304,410	$6.1m0.98%	0.98%	New
24	PLIANT THERAPEUTICS INC COM PLRX	PLRX	288,949	$5.2m0.84%	0.84%	Reduced -1.1m	-1,141,051 -79.8%
25	LYRA THERAPEUTICS INC COM LYRA	LYRA	924,170	$3.8m0.61%	0.61%	Unchanged
26	AEGLEA BIOTHERAPEUTICS INC COM AGLE	AGLE	6,343,221	$2.9m0.46%	0.46%	New
27	BLACK DIAMOND THERAPEUTICS I COM BDTX	BDTX	353,629	$1.8m0.29%	0.29%	New
28	RALLYBIO CORP COM COM		268,532	$1.5m0.24%	0.24%	Unchanged
29	AFFIMED N V COM COM		1,428,571	$854.6k0.14%	0.14%	Unchanged
30	AVALO THERAPEUTICS INC COM NEW COM NEW		1,250,000	$444.0k0.07%	0.07%	Added +250.0k	+250,000 25.0%

Sold out since Q1 2023

Security	Ticker	Shares held before	Value then
DICE THERAPEUTICS INC		819,000	$23.5m819.0k shares
AEROVATE THERAPEUTICS INC		833,927	$16.8m833.9k shares
VECTIVBIO HLDG AG		1,866,000	$15.9m1.9m shares
ANNEXON INC ANNX	ANNX	3,220,050	$12.4m3.2m shares
FULCRUM THERAPEUTICS INC FULC	FULC	1,307,094	$3.7m1.3m shares